Page last updated: 2024-10-18

dihydroxyphenylalanine and Hepatitis B Virus Infection

dihydroxyphenylalanine has been researched along with Hepatitis B Virus Infection in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Criswell, SR1
Perlmutter, JS1
Crippin, JS1
Videen, TO1
Moerlein, SM1
Flores, HP1
Birke, AM1
Racette, BA1

Other Studies

1 other study available for dihydroxyphenylalanine and Hepatitis B Virus Infection

ArticleYear
Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
    Archives of neurology, 2012, Volume: 69, Issue:3

    Topics: Caudate Nucleus; Ceruloplasmin; Dihydroxyphenylalanine; End Stage Liver Disease; Hepatitis B; Humans

2012